[#item_full_content] Trulieve Cannabis stock has seen its consensus analyst price target edge down slightly from $19.16 to $18.87 in recent market updates. While this change appears modest, it reflects a blend of cautious optimism about the company’s operational resilience and profitability, balanced against ongoing industry risks. Stay tuned to learn how you can keep up with evolving perspectives that influence the changing narrative surrounding Trulieve’s stock. Stay updated as the Fair Value for Trulieve… Read More
